DXCM Falls On CGM Rivalry, ZYNE Firms Up, SPPI In Limelight, Big …

Shutterstock photo

(RTTNews.com) – The following are some of the biotech stocks that made their way onto the Day’s Gainers Losers’ list of September 28, 2017.

GAINERS

1. Zynerba Pharmaceuticals Inc. (ZYNE)

Gained 52.50% to close Thursday’s (Sep.28) trading at $9.44.

News: The Company reported positive top line results from its phase II trial of ZYN002 cannabidiol (CBD) gel in pediatric and adolescent patients with Fragile X syndrome.

In the trial, dubbed FAB-C, ZYN002 cannabidiol gel in pediatric and adolescent patients with Fragile X syndrome met its primary endpoint, achieving a 46% improvement in the total score of Anxiety, Depression, and Mood Scale (ADAMS) at week twelve compared to baseline.

2. Spectrum Pharmaceuticals Inc. (SPPI)

Gained 22.97% to close Thursday’s trading at $13.49.

News: The

... read more at: http://www.nasdaq.com/article/dxcm-falls-on-cgm-rivalry-zyne-firms-up-sppi-in-limelight-big-day-awaits-mnkd-20170928-01406

by